Connect With a Global Community of Experts
Are you committed to supporting the development and commercialization of gene therapies across rare and high-prevalence diseases?
The 9th Gene Therapy Development Summit is your gateway to connect with the most influential minds in gene therapy, at a time when confidence in the space is beginning to rise again. Following a period of reduced investment, the gene therapy sector is showing signs of renewed momentum. With Eli Lilly’s $260 million acquisition of Adverum Biotechnologies and Arbor Biotechnology’s $70 million Series C, there is a clear uptick in investor confidence. While FDA approvals and late-stage clinical progress continue to accelerate, significant barriers remain across manufacturing, clinical execution, regulatory pathways, and market access.
If your solutions address these critical challenges, this summit offers direct access to 100+ senior decision-makers from biopharma, academia, and regulatory bodies, each actively seeking strategic and technical partners to help advance their programs. Ready to align your brand with a high-level, intimate audience of gene therapy leaders?
Let’s explore bespoke partnership opportunities tailored to your goals.
What to Expect?
Position Yourself as the Leading Gene Therapy Solution Provider
Showcase your expertise to a targeted audience of decision-makers actively developing gene therapies and seeking strategic and technical support to overcome key development challenges.
Stay at the Forefront of Gene Therapy Innovation
Gain direct insight from industry leaders to better understand the evolving hurdles in manufacturing, delivery, and regulatory strategy - so you can refine and tailor your solutions effectively.
Build Meaningful Connections with Gene Therapy Pioneers
Take advantage of 8+ hours of dedicated networking with senior figures from large pharma, emerging biotechs, and academic institutions driving the future of gene therapy.
Boost Your Brand Visibility & Credibility
Leverage branding opportunities and share your latest data, whether it’s on vector design, targeted delivery, or scalable manufacturing, to leave a lasting impression on the industry’s most influential players.
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Get in touch with Angus Booth to request more information.
Angus Booth
Business Development Manager
Gene Therapy Development Summit
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.